COVID‐19 in vaccinated versus unvaccinated hematologic malignancy patients is a research paper published in Transplant Infectious Disease (2022). On theSindex it has a DataRank of 0.469. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.177
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
California Department of Public Health
Grant: NU50CK000539
National Heart, Lung and Blood Institute
Grant: K23HL138461-01A1
the National Institutes of Health
Grant: R33AI129455
United States Centers for Disease Control
Grant: 75D30121C10991
NIAID NIH HHS
Grant: T32 AI007641
National Institutes of Health
Grant: 5R21AI129455-02
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1K23HL138461-01A1
Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic Sequencing
Innovative Genomics Institute Canadian Institutes of Health Research
Innovative Genomics Institute Canadian Institutes of Health Research
FWCI
0.46
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals